State Government Victoria Australia Department of Health header
State Government Victoria
Victorian Government Health Information
Health Home
Main A to Z Index | Site Map | About Health  
Safer systems saving livesSafer systems saving lives
    Health home > Safer Systems - Saving Lives home > The interventions > Improving care for acute myocardial infarction  
 

Improving care for acute myocardial infarction

Page content: Toolkit | Tools | FAQs | References | Bibliography

The acute myocardial infarction intervention uses some of the concepts of ‘bundle’ care but not all aspects are mandatory, they are implemented depending on individual patient conditions (for example, smoking cessation and ACE-inhibitors for systolic dysfunction).

Toolkit

Adobe acrobat pdf icon Improving care for acute myocardial infarction toolkit (401kb, pdf)

Tools

Microsoft Word icon Improving Care for Acute Myocardial Infarction – Audit Summary (81kb, MS Word)

Microsoft Word icon Improving AMI care - STEMI & Non-STEMI Discharge Audit Tool (71kb, MS word)

Microsoft Word icon Improving AMI care - During Hospitalisation Audit Tool (63kb, MS word)

Microsoft Word icon Improving AMI care - Non-STEMI (Admission) Audit Tool (59kb, MS word)

Microsoft Word icon Improving AMI care - STEMI (Admission) Audit Tool (58kb, MS word)

FAQs

Adobe acrobat pdf icon Safer Systems Saving Lives FAQs - February 2006 (327kb, pdf)

Should the time-frame for receipt of Aspirin on the admission audit tool for both STEMI and non-STEMI be “within 30 minutes” of arrival?

The toolkit states that the patient should receive an antiplatelet agent "before, or within 24 hours of admission". The term 'before' is an indication of the intended optimal time. Twenty-four hours is mentioned as a cut off time for the sake of the audit.

Can patients diagnosed with unstable angina be included in the audits for non-STEMI?

The Heart Foundation’s 'Management of Unstable Angina Guideline - 2000' identifies the distinction between unstable angina and non-STEMI as being 'cloudy' and the diagnoses of unstable angina, minor myocardial damage and non-STEMI representing a continuum1.

At the time of admission, it is likely that patients with unstable angina will receive the same care as patients with non-STEMI, and may continue to receive the same level of care throughout their stay. The point really is about the care that is received. If a patient diagnosed with unstable angina is receiving care as per the bundle, by all means audit accordingly.

Our hospital is often required to send patients to another hospital for treatment. If this occurs, for example, with an AMI patient, how is the patient represented in our data collection?

If possible exclude these patients from the audit. If it is not possible to exclude them because the sample size would be adversely affected, you can demonstrate compliance in care for the period the patient is at your hospital. If the patient receives all the components for STEMI admission, then is transferred, you should consider this patient to be compliant. The same will be true for the receiving hospital, if the patient arrives after receiving the admission components at your facility, then the receiving hospital will concentrate on demonstrating compliance with during hospitalisation and discharge care.

The compliance measure for AMI implies that all patients need to be included. We are concerned that this is a large undertaking, especially as the other interventions are only required to collect data on up to 20 patients. Can you comment on this?

In the interests of consistency, the AMI compliance measure can be limited to a sample of ‘up to 20 patients’ as for the other interventions (apart from RRS).

The compliance measure will be understood as:

The sample will be the number of patients audited.

References

  • Hennekens, CH, Albert, CM, Godfried, SL, Gaziano, JM, Buring, JE, 1996, 'Adjunctive drug therapy of acute myocardial infarction – evidence from clinical trials', New England Journal of Medicine, Volume 335, pp 1660-1667.

    Adjunctive drug therapy of acute myocardial infarction – evidence from clinical trials (External link)
    http://content.nejm.org/cgi/content/extract/335/22/1660

  • Hung, J, 2003, ‘Aspirin for cardiovascular disease prevention’, Medical Journal of Australia, Volume 179, Number 4, pp 147- 152.

    Aspirin for cardiovascular disease prevention (External link)
    http://www.mja.com.au/public/issues/179_03_040803/hun10816_fm.html

  • McGlynn, EA, Asch, SM, Adams, J, Keesey, J, Hicks, J, DeCristofaro, A, Kerr, EA, 2003, ‘The quality of health care delivered to adults in the United States’, New England Journal of Medicine, Volume 348, pp 2635-2645.

    The quality of health care delivered to adults in the United States (External link)
    http://content.nejm.org/cgi/content/abstract/348/26/2635

  • National Heart Foundation of Australia and Australian Cardiac Rehabilitation Association, 2004, Recommended framework for cardiac rehabilitation, Canberra.

    Recommended framework for cardiac rehabilitation (External link)
    http://www.heartfoundation.com.au/downloads/CR_04_Rec_Final.pdf

Bibliography

  • Ian A Scott, Charles P Denaro, Cameron J Bennett, Annabel C Hickey, Alison M Mudge, Judy L Flores, Daniela C J Sanders, Justine M Thiele, Beres Wenck, John W Bennett and Mark A Jones, 2004. ‘Achieving better in-hospital and after-hospital care of patients with acute cardiac disease’, Medical Journal of Australia, Volume 180, pp. 82-88.

  • Achieving better in-hospital and after-hospital care of patients with acute cardiac disease (External link)
    http://www.mja.com.au/public/issues/180_10_170504/sco10025_fm.pdf

 

 
 
Last updated: 15 June, 2007
This web site is managed and authorised by the Statewide Quality Branch, Rural & Regional Health & Aged Care Services Division of the Victorian State Government, Department of Health, Australia

Copyright | Disclaimer | Privacy Statement | State Government of Victoria Home | Download Help

For general enquiries to the Department of Health telephone 61 3 90960000